1. Academic Validation
  2. The interaction of O-GlcNAc-modified NLRX1 and IKK-α modulates IL-1β expression in M1 macrophages

The interaction of O-GlcNAc-modified NLRX1 and IKK-α modulates IL-1β expression in M1 macrophages

  • In Vitro Cell Dev Biol Anim. 2022 May;58(5):408-418. doi: 10.1007/s11626-022-00654-1.
Liqiong Chen  # 1 Yueliang Li  # 1 2 Shuxian Zeng 1 Shujuan Duan 1 Zhuanglin Huang 1 3 Yi Liang 4
Affiliations

Affiliations

  • 1 Department of Clinical Immunology, Institute of Laboratory Medicine, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, School of Medical Technology, Guangdong Medical University, Dongguan, 523808, China.
  • 2 Shenzhen Bao'an District Songgang People's Hospital, 2 Shajiang Road, Bao'an District, Shenzhen, 518100, Guangdong, China.
  • 3 Clinical Laboratory, Liangzhu Hospital, 1657 Moganshan Road, Yuhang District, Hangzhou, 311100, Zhejiang, China.
  • 4 Department of Clinical Immunology, Institute of Laboratory Medicine, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, School of Medical Technology, Guangdong Medical University, Dongguan, 523808, China. [email protected].
  • # Contributed equally.
Abstract

NOD-like receptor (NLR)X1 (NLRX1) is a negative regulator of inflammation by inhibiting nuclear factor-κB (NF-κB) signaling and downstream pro-inflammatory factors. However, its post-translational modification and how it participates in regulating the inflammatory responses in macrophages are still unclear. Here, we found that NLRX1 was modified with O-linked N-acetylglucosamine (O-GlcNAc). The interaction and co-localization between NLRX1 and O-GlcNAc transferase (OGT) was validated by co-immunoprecipitation and confocal microscopy analysis, and the nucleotide-binding domain (NBD) region of NLRX1 was required for its interaction with OGT. NLRX1 protein increased significantly after treatment with a high dose of OGT inhibitor OSMI-1. Elevated O-GlcNAcylation level promoted NLRX1 ubiquitination and decreased NLRX1 stability proved by ubiquitination and cycloheximide (CHX) chase experiments, and enhanced the interaction between NLRX1 and inhibitor of nuclear factor kappaB kinase-α (IKK-α), thus reducing the expression of inflammatory cytokine IL-1β in M1 macrophages. Together, our results indicate that the interaction between NLRX1 and O-GlcNAcylation coordinates and modulates the inflammatory process in macrophages.

Keywords

IKK-α; Inflammation; NF-κB; NLRX1; O-GlcNAcylation.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-12588
    99.98%, O-GlcNAcase Inhibitor